Skip to main content

Table 1 Data of two groups of patients with different outcomes

From: Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model

Variable

Death group (n = 214)

Survival group (n = 67)

χ2/t/Z

P value

Age > 65 years old [example (%)]

56(26.2%)

2(3%)

-

 < 0.001

Male [example (%)]

119(55.6%)

36(53.7%)

0.073

0.788

Intracranial hypertension [cases (%)]

136(63.6%)

40(59.7%)

0.323

0.570

Epilepsy [cases (%)]

64(29.9%)

20(29.8%)

0.001

0.993

Kps < 70 [example (%)]

143(66.8%)

58(86.5%)

9.768

0.002

Total tumor resection [cases (%)]

162(75.7%)

54(80.6%)

0.688

0.407

 NLR

2.60(2.01,3.40)

1.88(1.41,2.31)

5.853

 < 0.001

 MLR

0.28(0.21,0.36)

0.21(0.19,0.30)

3.178

0.001

 PLR

138(108,175)

116(88.5,160)

3.415

0.001

 FPR

76(62,110)

75(59,89.5)

1.737

0.082

 PNI

51.0(48.1,55.0)

51.4(49.0,52.7)

0.401

0.689

 SII

652.5(474,802)

406(278,511)

7.723

 < 0.001

Frontotemporal lobe [example (%)]

60(28.8%)

45(67.2%)

33.377

 < 0.001

Maximum diameter ≥ 5 cm[ example (%)]

73(34.1%)

27(40.3%)

0.852

0.356

Single tumor [cases (%)]

106(49.5%)

34(50.7%)

0.030

0.862

 NAA/Cr

0.67(0.30,1.00)

0.73(0.44,1.02)

1.538

0.124

 Cho/Cr

2.15(1.71,3.41)

1.96(1.72,3.20)

0.855

0.392

 Cho/NAA

4.08(1.77,10.00)

3.48(1.77,5.26)

1.697

0.090

 IDH mutant (example,%)

23(10.7%)

36(53.7%)

92.364

 < 0.001

 Low expression of Ki67 (e.g.,%)

151(70.5%)

44(67.2%)

-

1.000

 Low expression of p53 (e.g.,%)

184(28.8%)

49(28.8%)

5.946

0.015